Found vs bmiMD: Biology-First Plans vs Compounded Tirzepatide
Found vs bmiMD pits Found’s biology-first, medically supervised weight-loss plans against bmiMD’s compounded tirzepatide subscriptions. Early verdict: choose Found if you want a personalized program that centers hormones, metabolism, sleep and behavior, and choose bmiMD if you want compounded tirzepatide with multi-month pricing and free shipping.
Start Found’s biology-first plan
How Found and bmiMD differ at a glance
Found emphasizes a personalized, biology-based program and advertises getting started for as low as $39 with most insurance accepted. bmiMD focuses on compounded tirzepatide subscriptions with four billing options and free shipping, with prices from $179 month-to-month down to $139/mo for 12 months.
Key differences to weigh
1) Program approach and personalization
Found: Personalized medically supervised program built around each patient’s metabolic biology, targeting hormones, blood sugar regulation, sleep and behavior. Found markets a holistic whole-body approach rather than a single medication protocol for all patients.
bmiMD: Focuses on clinician-reviewed online treatment centered on compounded tirzepatide. The offering highlights clinician access and online refills, with less emphasis in the source on broader behavior or hormone programs.
See Found’s personalized plans
2) Medication types and regulatory notes
Found: Offers tirzepatide and semaglutide options and mentions compounded GLP-1s. The source explicitly states that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and that certain medications are FDA-approved for conditions other than weight. Rx is subject to provider review and clinical eligibility.
bmiMD: Offers compounded tirzepatide. The source states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment is available only when a licensed clinician determines it is medically appropriate.
3) Pricing structure and commitments
Found: Advertises affordable monthly plans and getting started for as low as $39. Found references multiple membership and pricing lines including starting at $49/mo for membership and mentions advertised pricing for branded GLP-1s via insurance with 12 month commitment in some offers. Insurance coverage, pricing and terms vary and copays, coinsurance and deductibles may apply.
bmiMD: Publishes four billing options with month-to-month at $179, three-month at $159/mo, six-month at $149/mo and 12-month at $139/mo. bmiMD notes the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
4) Shipping, delivery and clinician access
Found: States it handles insurance paperwork and that most insurance is now accepted; details include programs to help eligible Medicare Part D members access brand-name GLP-1 medications for as low as $50/mo under specific programs. Shipping/delivery specifics were not supplied beyond program terms.
bmiMD: Offers free shipping on every subscription order, online refills and delivery, and 24/7 clinician access. The source also describes medication preparation in state-licensed pharmacies and independent verification in FDA- and DEA-registered labs.
Comparison table: Found vs bmiMD
| Criteria | Found | bmiMD |
|---|---|---|
| Starting price | Get started for as low as $39 | $139/mo (12-month plan) starting; $179 month-to-month |
| Primary offering | Personalized medically supervised weight-loss programs; tirzepatide and semaglutide options | Compounded tirzepatide subscription |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | Not supplied; source focuses on subscription pricing |
| Billing options | Affordable monthly plans; membership pricing varies | 1, 3, 6, 12 month options with lower long-term equivalent |
| Shipping | Not supplied | Free subscription shipping on every order |
| Clinician access | Medically supervised program; Rx subject to clinician review | 24/7 clinician access; online refills and delivery |
| Regulatory note | Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy | Compounded medications are not FDA-approved and are not reviewed by FDA |
What the sources say about outcomes and guarantees
Found states that results vary by individual and notes offers and discounts with qualifiers. bmiMD advertises a 100% refund if a user is not eligible for the program and a “Best Price Guaranteed” statement in the source material; the source cautions confirming total prepaid charge and eligibility.
Check bmiMD eligibility and pricing
Conclusion: Found vs bmiMD
Found vs bmiMD is a choice between a personalized, biology-first, medically supervised program that accepts many insurers and advertises plans starting as low as $39, and a subscription-focused provider that centers on compounded tirzepatide with multi-month discounts and free shipping starting at $139/mo. The primary keyword Found vs bmiMD reflects this direct contrast.
Choose Found if…
You want a biology-based, medically supervised program that targets hormones, metabolism, sleep and behavior, wants to use insurance where accepted, and prefers start pricing as low as $39. Found emphasizes personalized plans and insurance handling.
Choose bmiMD if…
You want compounded tirzepatide with four billing options, lower long-term monthly equivalents at a 12-month rate, free subscription shipping and 24/7 clinician access. Confirm total prepaid charges, eligibility, and state availability before enrolling.